TIDMIMTK
RNS Number : 8913G
Imaginatik PLC
12 May 2014
Imaginatik Plc
("Imaginatik" or "the Company")
Result of General Meeting and Exercise of Options
Result of General Meeting
Imaginatik plc (AIM: IMTK.L), the world's first full service
innovation provider offering a range f technology products and
consultancy, is pleased to announce that at the Company's General
Meeting held earlier today, all resolutions put to shareholders
were duly passed.
Accordingly, 1,804,285,715 ordinary shares of 0.0625 pence each
in the capital of the Company ("Ordinary Shares") have been
allotted pursuant to the placing of and subscription for new
Ordinary Shares as announced on 25 April 2014 ("the Fundraising").
Application has been made for the new Ordinary Shares to be
admitted to trading on AIM ("Admission"). Admission is expected to
occur at 8.00 a.m. on 15 May 2014.
As at Admission, David Gammon will step down as a non-executive
director of the Company. The board of Imaginatik thanks him hugely
for his contribution during a key stage of the Company's
development.
Exercise of Options
Furthermore, the Company announces the exercise of options by
certain directors under the Imaginatik plc Enterprise Management
Incentive Scheme ("EMI Scheme").
As announced at the time of the Company's fundraise in May 2013,
pursuant to the Remuneration Re-investment Programme (further
details of which were set out in the circular sent to shareholders
on 26 April 2013) certain directors committed to subscribe for new
Ordinary Shares at a price of 0.0625 pence. The new Ordinary Shares
were to be issued following the contractual exercise of options
which were to be granted under the EMI Scheme in tranches between
31 May 2013 and 31 March 2014. To that end, on 12 May 2014, the
following directors have exercised the following options relating
to those granted between 31 December 2013 and 31 March 2014 at a
price of 0.0625 pence per Ordinary Share.
Director EMI Scheme Resulting % of total
Options Exercised Number of issued share
Shares Held capital,
as enlarged
by the EMI
Options
Matt Cooper,
Executive
Chairman 27,518,208 339,339,615 10.8
------------------- ------------- --------------
Shawn Taylor,
CFO 3,101,742 21,005,300 0.7
------------------- ------------- --------------
Total 30,619,950 360,344,915 11.5
------------------- ------------- --------------
The Company therefore announces the allotment of 30,619,950
Ordinary Shares under its block listing facility which were issued
for cash at a price of 0.0625 pence per Ordinary Share.
Directors' Shareholdings
The following table sets out the interests of the Directors in
the issued Ordinary Shares of the Company following Admission of
the new Ordinary Shares in relation to the Fundraising:
Director Number of Ordinary % of total issued
Shares share capital as
following Admission enlarged by new Ordinary
Shares in relation
to the Fundraising
Matt Cooper 1,053,625,330 21.3
--------------------- --------------------------
David Gammon* 226,156,850 4.6
--------------------- --------------------------
Shawn Taylor 28,148,157 0.6
--------------------- --------------------------
Simon Charles 59,511,771 1.2
--------------------- --------------------------
*stepping down as a non-executive director as at Admission
Total Voting Rights
The number of Ordinary Shares in issue following the exercise of
the options as per above is now 3,135,314,691. The Company does not
hold any Ordinary Shares in treasury. Therefore, the total number
of shares with voting rights in the Company is 3,135,314,691. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the share capital of the Company.
Following Admission of the new Ordinary Shares in relation to
the Fundraising, the number of Ordinary Shares in issue will be
4,939,600,406. The Company does not hold any Ordinary Shares in
treasury. Therefore, the total number of shares with voting rights
in the Company following Admission will be 4,939,600,406. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the share capital of the Company.
For further information please contact:
Imaginatik plc Tel: 020 7917
2975
Matt Cooper, Executive Chairman / Shawn
Taylor, CFO
finnCap Ltd Tel: 020 7220
0500
Charlotte Stranner/ Victoria Bates
Newgate Threadneedle Tel: 020 7653
9850
Caroline Evans-Jones / Hilary Millar
About Imaginatik
Imaginatik provides a range of Innovation solutions comprised of
consultancy, enterprise software and program management to deliver
innovation results to companies such as The World Bank, The Chubb
Group of Insurance Companies, State Farm, Exxon Mobil, Pfizer,
Goodyear, the Yorkshire Building Society, Pitney Bowes and Cargill.
Few companies possess the internal capability to consistently
generate fresh ideas, identify those worth pursuing and reliably
transform them into real, value-enhancing assets. Imaginatik's
mission is to help these companies build sustainable innovation
competencies.
Imaginatik is a public company whose shares are traded on the
AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World
Economic Forum Technology Pioneer with offices in Boston, MA, and
Fareham, UK. For more information visit www.imaginatik.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFDFIEFLSEFI
Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Abal (LSE:ABAL)
Historical Stock Chart
From Jul 2023 to Jul 2024
